YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FXGZP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,670
Award facts
- Contract value 100% obligated
- $1,670.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,670.13 by the Defense Logistics Agency (DLA) on August 21, 2025. The contract covers the supply of YF-VAX 1 Dose Vials, a yellow fever vaccine product, with an ultimate completion date of September 12, 2025. This delivery order was issued without a set-aside designation, and performance will be completed at the contractor's Park Ridge, Illinois location. The award represents a specific pharmaceutical supply requirement under DMS Pharmaceutical Group's existing relationship with the DLA for medical product distribution.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The IDC encompasses branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables across multiple product categories. As a established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group maintains a significant role in the DLA's pharmaceutical supply chain, ensuring vaccine and medication availability to military health facilities globally.
Quick answers
Who was awarded contract SPE2DB25FXGZP?
SPE2DB25FXGZP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FXGZP worth?
The government has obligated $1,670 on SPE2DB25FXGZP.
Is contract SPE2DB25FXGZP an order under another contract?
Yes. SPE2DB25FXGZP is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB25FXGZP competed?
The extent of competition for SPE2DB25FXGZP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award